Trulieve Cannabis (TRLV) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 65 sessions, June 10, 2026 to September 11, 2026
- Largest daily move
- -10.4% close of June 12, 2026
Company Description
Trulieve Cannabis (NYSE: TRLV) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.2B.
TRLV has gained 21.6% over the past month. The last closing price was $11.31.
For FY2025, Trulieve Cannabis reported revenue of $1.2B with net income of -$116.4M and diluted earnings per share of -$0.58. The company operates at a net profit margin of -9.8%.
This page collects what Stock Titan holds for TRLV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Trulieve Cannabis (TRLV) closed at $11.31 on September 11, 2026. Over the past month, the price has gained 21.6%.
TRLV Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Trulieve Cannabis has 10 recent news articles, with the latest published 7 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, conferences, earnings date. View all TRLV news →
SEC Filings
Trulieve Cannabis has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form POSASR, 1 Form 10-Q. The most recent filing was submitted on August 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRLV SEC filings →
Insider Radar
Insider selling at Trulieve Cannabis over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Trulieve Cannabis generated $1.2B in revenue in FY2025, retaining a 60.2% gross margin, operating income reached $143.5M (12.2% operating margin), and net income was -$116.4M, reflecting a -9.8% net profit margin. Diluted earnings per share stood at -$0.58. The company generated $272.8M in operating cash flow. With a current ratio of 4.43, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Trulieve Cannabis (TRLV) currently stands at 1.3 million shares, up 0.9% from the previous reporting period, representing 0.8% of the float. Since June 2026, short interest has increased by 351.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Trulieve Cannabis (TRLV) currently stands at 1.7 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 66% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.7 days.
TRLV Company Profile & Sector Positioning
Trulieve Cannabis (TRLV) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the NYSE.